Clinical Trials Directory

Trials / Conditions / HER2 Low Breast Carcinoma

HER2 Low Breast Carcinoma

7 registered clinical trials studyying HER2 Low Breast Carcinoma — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
NCT06224673
Laura Huppert, MD, BAPhase 2
RecruitingERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor an
NCT07198724
Sarah Sammons, MDPhase 1 / Phase 2
RecruitingDose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monothe
NCT06298084
Gustave Roussy, Cancer Campus, Grand ParisPhase 1 / Phase 2
Active Not RecruitingNeoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer
NCT06144944
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 3
RecruitingA Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer
NCT05911958
Henan Cancer HospitalPhase 2
RecruitingPRE-I-SPY Phase I/Ib Oncology Platform Program
NCT05868226
QuantumLeap Healthcare CollaborativePhase 1
CompletedTumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients
NCT05754047
Mahdis Bayat—